Andrew L. Johnson - Net Worth and Insider Trading

Andrew L. Johnson Net Worth

The estimated net worth of Andrew L. Johnson is at least $4,587 dollars as of 2024-05-11. Andrew L. Johnson is the CHIEF STRATEGY OFFICER of Panacea Life Sciences Holdings Inc and owns about 30,580 shares of Panacea Life Sciences Holdings Inc (PLSH) stock worth over $4,587. Details can be seen in Andrew L. Johnson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew L. Johnson has not made any transactions after 2019-12-18 and currently still holds the listed stock(s).

Transaction Summary of Andrew L. Johnson

To

Andrew L. Johnson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew L. Johnson owns 2 companies in total, including Panacea Life Sciences Holdings Inc (PLSH) , and Panacea Life Sciences Holdings Inc (PLSH) .

Click here to see the complete history of Andrew L. Johnson’s form 4 insider trades.

Insider Ownership Summary of Andrew L. Johnson

Ticker Comapny Transaction Date Type of Owner
PLSH Panacea Life Sciences Holdings Inc 2020-02-01 CHIEF STRATEGY OFFICER
PLSH Panacea Life Sciences Holdings Inc 2019-03-11 Chief Strategy Officer

Andrew L. Johnson Latest Holdings Summary

Andrew L. Johnson currently owns a total of 1 stock. Andrew L. Johnson owns 30,580 shares of Panacea Life Sciences Holdings Inc (PLSH) as of December 18, 2019, with a value of $4,587.

Latest Holdings of Andrew L. Johnson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PLSH Panacea Life Sciences Holdings Inc 2019-12-18 30,580 0.15 4,587

Holding Weightings of Andrew L. Johnson


Andrew L. Johnson Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew L. Johnson has made a total of 1 transactions in Panacea Life Sciences Holdings Inc (PLSH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Panacea Life Sciences Holdings Inc is the acquisition of 2,232 shares on December 18, 2019, which cost Andrew L. Johnson around $25,000.

Insider Trading History of Andrew L. Johnson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew L. Johnson Trading Performance

GuruFocus tracks the stock performance after each of Andrew L. Johnson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew L. Johnson is -72.91%. GuruFocus also compares Andrew L. Johnson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew L. Johnson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew L. Johnson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew L. Johnson

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -20.82
Relative Return to S&P 500(%) -25.16

Andrew L. Johnson Ownership Network

Ownership Network List of Andrew L. Johnson

No Data

Ownership Network Relation of Andrew L. Johnson


Andrew L. Johnson Owned Company Details

What does Panacea Life Sciences Holdings Inc do?

Who are the key executives at Panacea Life Sciences Holdings Inc?

Andrew L. Johnson is the CHIEF STRATEGY OFFICER of Panacea Life Sciences Holdings Inc. Other key executives at Panacea Life Sciences Holdings Inc include Chief Growth Officer Chesne Derek Du , director & CHIEF FINANCIAL OFFICER Ken Puzder , and director & 10 percent owner Ceed2med Llc .

Panacea Life Sciences Holdings Inc (PLSH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Panacea Life Sciences Holdings Inc (PLSH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Panacea Life Sciences Holdings Inc (PLSH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Panacea Life Sciences Holdings Inc (PLSH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Panacea Life Sciences Holdings Inc Insider Transactions

No Available Data

Andrew L. Johnson Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew L. Johnson. You might contact Andrew L. Johnson via mailing address: 80 Ne 4th Ave. Suite 28, Delray Beach Fl 33483.

Discussions on Andrew L. Johnson

No discussions yet.